162 related articles for article (PubMed ID: 7657870)
1. Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study.
Mrowietz U; Färber L; Henneicke-von Zepelin HH; Bachmann H; Welzel D; Christophers E
J Am Acad Dermatol; 1995 Sep; 33(3):470-5. PubMed ID: 7657870
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
[TBL] [Abstract][Full Text] [Related]
3. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine as maintenance therapy in patients with severe psoriasis.
Shupack J; Abel E; Bauer E; Brown M; Drake L; Freinkel R; Guzzo C; Koo J; Levine N; Lowe N; McDonald C; Margolis D; Stiller M; Wintroub B; Bainbridge C; Evans S; Hilss S; Mietlowski W; Winslow C; Birnbaum JE
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):423-32. PubMed ID: 9091474
[TBL] [Abstract][Full Text] [Related]
5. A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study.
Grossman RM; Thivolet J; Claudy A; Souteyrand P; Guilhou JJ; Thomas P; Amblard P; Belaich S; de Belilovsky C; de la Brassinne M
J Am Acad Dermatol; 1994 Jul; 31(1):68-74. PubMed ID: 8021375
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
Dermatology; 1993; 187 Suppl 1():19-29. PubMed ID: 8369576
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. The German Multicenter Study.
Christophers E; Mrowietz U; Henneicke HH; Färber L; Welzel D
J Am Acad Dermatol; 1992 Jan; 26(1):86-90. PubMed ID: 1732342
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
[TBL] [Abstract][Full Text] [Related]
9. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.
Faerber L; Braeutigam M; Weidinger G; Mrowietz U; Christophers E; Schulze HJ; Mahrle G; Meffert H; Drechsler S
Am J Clin Dermatol; 2001; 2(1):41-7. PubMed ID: 11702620
[TBL] [Abstract][Full Text] [Related]
11. Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.
Borghi A; Corazza M; Mantovani L; Bertoldi AM; Giari S; Virgili A
Int J Dermatol; 2012 Dec; 51(12):1512-6. PubMed ID: 23171021
[TBL] [Abstract][Full Text] [Related]
12. Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure.
Lowe NJ; Wieder JM; Rosenbach A; Johnson K; Kunkel R; Bainbridge C; Bourget T; Dimov I; Simpson K; Glass E; Grabie MT
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):710-9. PubMed ID: 8912566
[TBL] [Abstract][Full Text] [Related]
13. Low-dose cyclosporine A improves severe disabling psoriasis in Latin America. Latin American Multicenter Study.
Honeyman JF; Sánchez L; Valdés P
Int J Dermatol; 1995 Aug; 34(8):583-8. PubMed ID: 7591445
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study.
Colombo D; Cassano N; Altomare G; Giannetti A; Vena GA
Int J Immunopathol Pharmacol; 2010; 23(4):1143-52. PubMed ID: 21244763
[TBL] [Abstract][Full Text] [Related]
15. Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy.
Ellis CN; Fradin MS; Hamilton TA; Voorhees JJ
Arch Dermatol; 1995 Jul; 131(7):791-5. PubMed ID: 7611794
[TBL] [Abstract][Full Text] [Related]
16. Morphologic renal changes during cyclosporine treatment of psoriasis. Studies on pretreatment and posttreatment kidney biopsy specimens.
Zachariae H; Hansen HE; Kragballe K; Olsen S
J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):415-9. PubMed ID: 1564147
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine therapy for psoriasis: a cell cycle-derived dosing schedule.
Goodman MM; White GM; McCormick A; McCullough J; Weinstein G
J Am Acad Dermatol; 1992 Oct; 27(4):594-8. PubMed ID: 1401311
[TBL] [Abstract][Full Text] [Related]
18. Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.
Ohtsuki M; Nakagawa H; Sugai J; Ozawa A; Ohkido M; Nakayama J; Hanada J; Morimoto Y; Jimbow K; Horikoshi T; Kitahara H; Tamaki K; Urabe K; Hori Y
J Dermatol; 2003 Apr; 30(4):290-8. PubMed ID: 12707465
[TBL] [Abstract][Full Text] [Related]
19. Intermittent cyclosporin A treatment of severe plaque psoriasis. Long-term follow-up of 26 patients.
Peluso AM; Bardazzi F; Tosti A; Varotti C
Acta Derm Venereol Suppl (Stockh); 1994; 186():90-1. PubMed ID: 8073851
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of cyclosporine in the treatment of psoriasis.
Grossman RM; Chevret S; Abi-Rached J; Blanchet F; Dubertret L
Arch Dermatol; 1996 Jun; 132(6):623-9. PubMed ID: 8651712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]